[Longterm psychosis and sultopride].
The action of sultopride was studied in patients with chronic psychosis during rehospitalization for a psychopathic episode. 22 patients (8 manic-depressive psychoses and 14 schizophrenias) were given sultopride as the sole therapy, in a daily dose of 4 vials. After symptomatic improvement therapy was continued by the oral route. Under these conditions, a satisfactory response was recorded in 81.8% of patients. These results are confronted with those previously obtained in a comparable group of patients given phenothazines. A statistically significant difference was found, with sultopride being more effective and acting more rapidly than phenothiazines.